Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia

Biomedicine and Pharmacotherapy

Volumn 42, Issue 9, 1988, Pages 597-604

  Komada, Y ^a   Azuma, E ^a   Yamamoto, H ^a   Tanaka, S ^a   Shimizu, K ^a   Kamiya, H ^a   Sakurai, M ^a   Izawa, T ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; BONE MARROW; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOTHERAPY; INFANT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; HUMAN; IMMUNOTHERAPY; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0024240502     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)